GPT and metabolic dysfunction-associated steatotic liver disease: By using ALT as a diagnostic test, the National Health and Nutrition Examination Surveys (NHANES) in the USA has reported a NAFLD prevalence of 6%–11.5% among adolescents, tripled from 3.9% in 1988–1994 to 10.7% in 2007–2010 (195).